Summary
Guardant Health, Inc. (GH) has filed an 8-K report on January 12, 2026, disclosing preliminary unaudited financial information for the fourth quarter and full year ended December 31, 2025. This information is detailed in a press release furnished as Exhibit 99.1 to the filing. While specific financial metrics are not detailed in the 8-K itself, investors should refer to the press release for details on revenue, earnings, and other key performance indicators relevant to the period. In addition to the financial results, the Company also announced that a presentation for the 2026 J.P. Morgan Healthcare Conference, scheduled for January 12, 2026, will be made available on their investor website. This presentation is likely to offer further insights into the Company's strategic priorities, market outlook, and potentially updated guidance. Investors are advised to review both the press release and the conference presentation for a comprehensive understanding of Guardant Health's current financial standing and future prospects.
Key Highlights
- 1Guardant Health released preliminary, unaudited financial results for Q4 and FY 2025 on January 11, 2026.
- 2The detailed financial information is available in a press release furnished as Exhibit 99.1.
- 3The company will present at the 2026 J.P. Morgan Healthcare Conference on January 12, 2026.
- 4A presentation for the J.P. Morgan Healthcare Conference will be accessible on the Guardant Health investor website.
- 5Information furnished in this 8-K is not deemed 'filed' for certain regulatory purposes, but is important for investor awareness.